GBA1 and Parkinson disease: Previous studies have shown that GBA1 inhibition in the mouse brain recapitulates the redistribution of neutral lipids between dopaminergic neurons and glia in the substantia nigra of human PD patients, with increased neutral lipid content in neurons and microglia and decreased neutral lipids in astrocytes [18].